Scholarlink

<p>This study developed a self-administered metacognitive coping strategy scale that reflects metacognition changes resulting from metacognitive training. A 25-item scale with four subscales was developed based on data obtained from 286 adults in the general population in Japan. The statistical reliability of the scale, including the retest reliability, ranged from moderate to high. Correlations with other scales supported the developed scale’s expected validity. A survey was also conducted among 20 people with schizophrenia. The scores on this scale were positively correlated with adaptive coping and beliefs, and negatively correlated with delusions, and there was no significant correlation with anxiety or depression. This evidence suggested some of the clinical validity. Additionally, in terms of the cognitive behavioral therapy aspect of metacognitive training, the metacognitive coping strategy scale would be a useful tool for participants of metacognitive training and trainers in practice. In the future, it will be necessary to investigate a larger clinical sample to confirm clinical validity, and to confirm the usefulness in clinical practice by tracking changes over time through metacognitive training.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Development of a self-administered metacognitive coping strategies scale for metacognitive training: an exploratory study examining the relationship between coping awareness and psychopathology

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年3月26日

查看全文
  • Takuma Ishigaki,
  • Yuki Nishiguchi,
  • Takeshi Shimada

摘要

This study developed a self-administered metacognitive coping strategy scale that reflects metacognition changes resulting from metacognitive training. A 25-item scale with four subscales was developed based on data obtained from 286 adults in the general population in Japan. The statistical reliability of the scale, including the retest reliability, ranged from moderate to high. Correlations with other scales supported the developed scale’s expected validity. A survey was also conducted among 20 people with schizophrenia. The scores on this scale were positively correlated with adaptive coping and beliefs, and negatively correlated with delusions, and there was no significant correlation with anxiety or depression. This evidence suggested some of the clinical validity. Additionally, in terms of the cognitive behavioral therapy aspect of metacognitive training, the metacognitive coping strategy scale would be a useful tool for participants of metacognitive training and trainers in practice. In the future, it will be necessary to investigate a larger clinical sample to confirm clinical validity, and to confirm the usefulness in clinical practice by tracking changes over time through metacognitive training.